1. Home
  2. ADAP vs PERF Comparison

ADAP vs PERF Comparison

Compare ADAP & PERF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAP
  • PERF
  • Stock Information
  • Founded
  • ADAP 2008
  • PERF 2015
  • Country
  • ADAP United Kingdom
  • PERF Taiwan
  • Employees
  • ADAP N/A
  • PERF N/A
  • Industry
  • ADAP Biotechnology: Pharmaceutical Preparations
  • PERF Computer Software: Prepackaged Software
  • Sector
  • ADAP Health Care
  • PERF Technology
  • Exchange
  • ADAP Nasdaq
  • PERF Nasdaq
  • Market Cap
  • ADAP 212.3M
  • PERF 197.6M
  • IPO Year
  • ADAP 2015
  • PERF N/A
  • Fundamental
  • Price
  • ADAP $0.62
  • PERF $2.26
  • Analyst Decision
  • ADAP Strong Buy
  • PERF Buy
  • Analyst Count
  • ADAP 4
  • PERF 2
  • Target Price
  • ADAP $2.79
  • PERF $4.00
  • AVG Volume (30 Days)
  • ADAP 2.3M
  • PERF 134.7K
  • Earning Date
  • ADAP 11-13-2024
  • PERF 10-29-2024
  • Dividend Yield
  • ADAP N/A
  • PERF N/A
  • EPS Growth
  • ADAP N/A
  • PERF N/A
  • EPS
  • ADAP N/A
  • PERF 0.05
  • Revenue
  • ADAP $175,041,000.00
  • PERF $58,445,000.00
  • Revenue This Year
  • ADAP $204.91
  • PERF $15.44
  • Revenue Next Year
  • ADAP N/A
  • PERF $13.52
  • P/E Ratio
  • ADAP N/A
  • PERF $44.53
  • Revenue Growth
  • ADAP 146.27
  • PERF 15.84
  • 52 Week Low
  • ADAP $0.43
  • PERF $1.70
  • 52 Week High
  • ADAP $2.05
  • PERF $3.77
  • Technical
  • Relative Strength Index (RSI)
  • ADAP 37.29
  • PERF 57.35
  • Support Level
  • ADAP $0.57
  • PERF $2.22
  • Resistance Level
  • ADAP $0.61
  • PERF $2.57
  • Average True Range (ATR)
  • ADAP 0.04
  • PERF 0.27
  • MACD
  • ADAP -0.00
  • PERF -0.01
  • Stochastic Oscillator
  • ADAP 27.46
  • PERF 50.01

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.

About PERF Perfect Corp.

Perfect Corp is engaged in the beauty and fashion tech revolution, providing omni-channel integrated solutions that are ultra-personalized, interactive and engaging, from online to in-store through beauty mirrors. Geographically, the company has a presence in the United States, France, Japan and Others.

Share on Social Networks: